Shutai Shen: Plans to raise no more than 1.253 billion yuan for innovative drug research and development projects and to supplement working capital.

2025-09-09 09:00:28

Abstract generation in progress

Jin10 data reported on September 9, Shutai Shen announced that the company intends to raise a total of no more than (including) RMB 125,300.00 million from no more than 35 investors. The net amount of the raised funds after deducting related issuance costs will be used entirely for innovative drug research and development projects and to supplement working capital. The pricing benchmark date for this issuance to specific objects is the first day of the issuance period. The issuance price will not be lower than 80% of the average trading price of the company's stock over the 20 trading days prior to the pricing benchmark date. The stocks issued to specific objects may not be transferred within 6 months from the end of this issuance, unless otherwise stipulated by laws and regulations regarding the lock-up period.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.